BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8033589)

  • 21. Stimulation of Na+,K+,Cl- cotransport by forskolin-activated adenylyl cyclase in fetal human nonpigmented epithelial cells.
    Crook RB; Polansky JR
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3374-83. PubMed ID: 7520028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J; Waelbroeck M; Chatelain P; Robberecht P
    Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of vasoactive intestinal peptide receptors in human liver.
    Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
    Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H; Shima K; Said SI
    Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of intracellular cyclic AMP and stimulation of adenylate cyclase activity by vasoactive intestinal peptide and glucagon in the retinal pigment epithelium.
    Koh SW; Chader GJ
    J Neurochem; 1984 Dec; 43(6):1522-6. PubMed ID: 6092540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D1 stimulation of Na+,K+,Cl- cotransport in human NPE cells: effects of multiple hormones.
    Riese K; Beyer AT; Lui GM; Crook RB
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1444-52. PubMed ID: 9660493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bimodal regulation of adenylate cyclase by prostaglandin E2 receptors in porcine ciliary epithelium.
    Sano N; Shichi H
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):765-9. PubMed ID: 8259373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells.
    Hohmann EL; Tashjian AH
    Endocrinology; 1984 Apr; 114(4):1321-7. PubMed ID: 6323142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response and level of beta-adrenergic, vasoactive intestinal peptide, and PACAP receptors during the circadian cycle.
    Hirota A; Kiuchi Y; Nii H; Gregory DS
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1708-18. PubMed ID: 9286259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
    Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
    Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bicarbonate secretion in the guinea pig duodenum: functional characterization of peptide hormone receptors in duodenal enterocytes.
    Reimer R; Odes HS; Beil W; Schwenk M; Muallem R; Sewing KF
    Pharmacology; 1996 Jun; 52(6):339-46. PubMed ID: 8844783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A; Rousset M; Laburthe M
    Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
    Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC; Hamel LT; Wax MB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts.
    Beed EA; O'Dorisio MS; O'Dorisio TM; Gaginella TS
    Regul Pept; 1983 Apr; 6(1):1-12. PubMed ID: 6306732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ca2+ mobilization in nontransformed ciliary nonpigmented epithelial cells.
    Ohuchi T; Yoshimura N; Tanihara H; Kuriyama S; Ito S; Honda Y
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1696-705. PubMed ID: 1348498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.